Log in to save to my catalogue

The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and in...

The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and in...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_31bb61fc1f184e05ad3419dfa1a44b03

The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD)

About this item

Full title

The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD)

Publisher

England: BioMed Central

Journal title

Molecular medicine (Cambridge, Mass.), 2020-06, Vol.26 (1), p.54-54, Article 54

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

Our objective was to investigate the efficacy of the beta-3 adrenergic receptor (β3-AR) agonist BRL37344 for the prevention of liver steatosis and inflammation associated with nonalcoholic fatty liver disease (NAFLD).
Four groups were established: a control group (given a standard diet), a high-fat diet (HFD) group, an HFD + β3-AR agonist (β3-AG...

Alternative Titles

Full title

The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_31bb61fc1f184e05ad3419dfa1a44b03

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_31bb61fc1f184e05ad3419dfa1a44b03

Other Identifiers

ISSN

1076-1551

E-ISSN

1528-3658

DOI

10.1186/s10020-020-00164-4

How to access this item